CANY
GCO icon

Caxton Associates (New York)’s Genesco GCO Stock Holding History

Caxton Associates (New York)’s Portfolio GCO Stock Details GCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$440K Sell
10,299
-3,076
-23% -$101K 0.01% 357
2024
Q3 		$363K Hold
13,375
– – 0.01% 416
2024
Q2 		$346K Hold
13,375
– – 0.01% 390
2024
Q1 		$376K Hold
13,375
– – 0.02% 355
2023
Q4 		$471K Sell
13,375
-3,010
-18% -$92.6K 0.02% 335
2023
Q3 		$505K Buy
+16,385
New +$465K 0.07% 242

Other funds holding GCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Associates (New York)'s GCO Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Genesco (GCO) stake by 23% in Q4 2024, selling an estimated $101K and leaving 10,299 shares worth $440K. The position accounts for 0.01% of the portfolio, ranked #357.

Caxton Associates (New York) first reported a position in GCO in Q3 2023 and has held it in 6 quarters since. The position peaked at $505K in Q3 2023. 133 funds tracked by Wall St. Rank hold GCO as of Q4 2024.

  • Caxton Associates (New York) held 10,299 shares of Genesco worth $440K as of Q4 2024.
  • Caxton Associates (New York) sold 3,076 Genesco shares in Q4 2024, an estimated $101K.
  • Genesco made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #357 holding.
  • Caxton Associates (New York) first reported a position in Genesco in Q3 2023 and has held it in 6 quarters since.
  • Caxton Associates (New York)'s Genesco position peaked at $505K in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Genesco as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.